Hercules1
1 year ago
I revise my estimates:
this can do $15 to $17 today.
$12.5 million bet on this stock is enough to convince me.
Evelo Biosciences
The Trade: Evelo Biosciences, Inc. (NASDAQ: EVLO) 10% owner Noubar Afeyan acquired a total of 5,411,255 shares an average price of $2.31. To acquire these shares, it cost around $12.5 million.
Whatβs Happening: Evelo Biosciences recently announced a $25.5 million private placement.
What Evelo Biosciences Does: Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body.